Evaluation

MATERIALS AND METHODS
Preparation of Leukocytes
The Of the filtrate, 0.1 ml was added to 0.4 ml of 1 mM ascorbic acid in 0.2 N sodium hydroxide.
The nitroblue tetrazolium was quantitatively reduced to formazan by this procedure, and the insoluble residue was collected on a 0.3 j Millipore filter. The entire filter was dissolved in 2 ml of p-dioxane with heating to 85#{176}C, and optical density was immediately determined at 580 nm. The actual concentration of the filtrate was approximately 318 g/ml.
Formazan, prepared as described above, was weighed on tared Millipore filters, and its optical density was determined, thereby providing a conversion factor from optical density to micrograms of formazan (14.14 ig formazan/optical density unit, for a 1 cm light path in dioxane at 25#{176}C).
Preparation of Serum
Whole blood was allowed to clot at room temperature; the serum was separated by centrifugation and was analyzed immediately or frozen at -70#{176}C.
Opsonization of the Emulsion
Test serum, 0.4 ml, or Krebs-Ringer phosphate medium (control) was incubated with 0.4 ml of the paraffin oil particles at 37#{176}C for 15 mm.
Incu bations
To two siliconized glass or polycarbonate plastic 15-mi centrifuge tubes was added 0.015 ml of 0.i M freshly prepared potassium cyanide in Krebs-Ringer phosphate medium and 0.4 ml of the leukocyte suspension. Krebs-Ringer phosphate medium, 0.4 ml, was added to the first tube, and nitroblue tetrazolium solution, 0.4 ml, was added to the second tube. The tubes were shaken in a water bath at 37#{176}C for 5 mm, and then 0. 
